American Healthcare REIT, Inc. (AHR)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
---|---|---|---|---|
Total revenues | 542,503 | 476,834 | 458,013 | |
Interest expense, net | 22,632 | 30,395 | 30,596 | |
Other income, net | 1,480 | 2,138 | 3,106 | |
Loss from unconsolidated entities | -1,238 | -2,123 | -1,035 | |
Impairment of real estate investments | 12,659 | - | - | |
(loss) gain on dispositions of real estate investments, net | -2,676 | -4 | -2 | |
(loss) gain in fair value of derivative financial instruments | -629 | -8,967 | 388 | |
Foreign currency gain (loss) | 2,742 | 2,689 | 82 | |
Total net other expense | -35,612 | -36,662 | -28,057 | |
Rental expenses | 12,990 | 13,150 | 13,323 | |
General and administrative | 14,943 | 11,921 | 11,746 | |
Depreciation and amortization | 41,941 | 44,246 | 45,264 | |
Property operating expenses | 426,285 | 417,128 | 402,564 | |
Business acquisition expenses | -79 | 3,537 | 15 | |
Total expenses | 496,080 | 489,982 | 472,912 | |
Real estate revenue | - | 46,980 | 46,568 | |
Total revenues and grant income | - | 523,814 | - | |
Total revenues and grant income | - | - | 504,581 | |
Income before income taxes | 10,811 | -2,830 | 3,612 | |
Income tax expense | 732 | 263 | 686 | |
Net income (loss) | 10,079 | -3,093 | 2,926 | |
Net income attributable to noncontrolling interests | 171 | 1,033 | 947 | |
Net income (loss) attributable to controlling interest | 9,908 | -4,126 | 1,979 | |
Net loss per share of common stock, class t common stock and class i common stock attributable to controlling interest basic (in dollars per share) | 0.06 | -0.03 | 0.01 | |
Net loss per share of common stock, class t common stock and class i common stock attributable to controlling interest diluted (in dollars per share) | 0.06 | -0.03 | 0.01 | |
Weighted average number of shares of common stock, class t common stock and class i common stock outstanding basic (in shares) | 160,499,581 | 133,732,745 | 130,532,144 | |
Weighted average number of shares of common stock, class t common stock and class i common stock outstanding diluted (in shares) | 161,143,556 | 133,732,745 | 130,689,889 |